AAN Unveils Overhauled Botulinum Toxin Guidelines

From NeurologyWire

The American Academy of Neurology (AAN) has adopted new guidelines for the use of botulinum toxins for blepharospasm, cervical dystonia (CD), headache, and adult spasticity. The new guidelines, published recently in Neurology, were unveiled at the AANs Annual Meeting in Vancouver and represent the first update since 2008. In the treatment of headac...

Login to read story

Wednesday, April 20, 2016

Show last days of articles

Alnylam Releases Data from Ongoing Phase 2 Open-Label Extens...

From NeurologyWire

Alnylam Pharmaceuticals, Inc. unveiled complete 18-month data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigati...Full story

AAN Unveils Overhauled Botulinum Toxin Guidelines

From NeurologyWire

The American Academy of Neurology (AAN) has adopted new guidelines for the use of botulinum toxins for blepharospasm, cervical dystonia (CD), headache...Full story

Tuesday, April 19, 2016

AAN Meeting: More than One Million Annual ER Visits Epilepsy...

From NeurologyWire

New data presented at the at the Annual Meeting of the American Academy of Neurology (AAN) in Vancouver suggest that there are substantial unmet needs...Full story

Friday, April 15, 2016

Marinus Pharmaceuticals Receives FDA Orphan Drug Designation...

From NeurologyWire

The FDA has granted Orphan Drug Designation to the intravenous (IV) formulation of a CNS-selective GABAA modulator, ganaxolone, for the treatment of s...Full story

Wednesday, April 13, 2016

Investigational Primary Progressive MS Agent Shows Promise i...

From NeurologyWire

An investigational agent for the treatment of primary progressive multiple sclerosis has shown considerable promise in new phase 3 data to be presente...Full story

Tuesday, April 12, 2016

Plant Peptide May Halt MS Progression

From NeurologyWire

New data suggests that circular plant peptides known as cyclotides may play an important role in treating T-cell mediated disorders such as multiple s...Full story

Survey Findings Suggest Low Awareness for ULS

From NeurologyWire

Findings from a new survey revealed that awareness of the signs and symptoms of adult Upper Limb Spasticity (ULS) is low among Americans. The survey w...Full story

Thursday, April 07, 2016

Pfizer and IBM Teaming Up On Remote Monitoring System for Pa...

From NeurologyWire

Pfizer Inc. and IBM are joining forces to develop innovative remote monitoring solutions aimed at transforming how clinicians deliver care to patients...Full story

Wednesday, April 06, 2016

Biomarker Analyses of Phase 2 Data Shows Potential for ALS A...

From NeurologyWire

Secondary analyses of Neuraltus Pharmaceuticals' Phase 2 clinical trial of its investigational treatment, NP001, for amyotrophic lateral sclerosis (AL...Full story

Data for Investigational Levodopa for Subcutaneous Infusion ...

From NeurologyWire

Recent data for the investigational levodopa/carbidopa agent ND0612 will be presented at the American Academy of Neurology (AAN) annual meeting in Van...Full story

Tuesday, March 29, 2016

Migraine Prevention Drug Shows Potential in Phase 2b Trial

From NeurologyWire

An investigational agent from Alder BioPharmaceuticals has shown promise for migraine prevention, according to new clinical trial data released by the...Full story

Thursday, March 24, 2016

Novel Concussion Assessment Technology Wins Research Support...

From NeurologyWire

Neuro Assessment Systems, Inc. and the Mayo clinic are set to collaborate on studying a new system for the assessment of central nervous system (CNS) ...Full story

Wednesday, March 23, 2016

Mobile Stroke Unit with Advanced CT Imaging Capabilities Lau...

From NeurologyWire

The University of Tennessee College of Medicine in Memphis, Tenn. recently introduced a comprehensive mobile stroke unit capable of conducting and pro...Full story

PCORI Seeking Advisory Panel Members

From NeurologyWire

The Patient-Centered Outcomes Research Institute (PCORI) has openings for researchers, clinicians and others on seven Advisory Panels and has extended...Full story